Kobayashi-Kirschvink, Koseki J. http://orcid.org/0000-0001-6590-3823
Comiter, Charles S. http://orcid.org/0000-0003-4201-1739
Gaddam, Shreya
Joren, Taylor
Grody, Emanuelle I. http://orcid.org/0000-0002-7177-3268
Ounadjela, Johain R.
Zhang, Ke
Ge, Baoliang
Kang, Jeon Woong http://orcid.org/0000-0003-2012-9023
Xavier, Ramnik J.
So, Peter T. C.
Biancalani, Tommaso http://orcid.org/0000-0001-9104-9755
Shu, Jian http://orcid.org/0000-0001-9390-9333
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Article History
Received: 4 November 2021
Accepted: 1 December 2023
First Online: 10 January 2024
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was a scientific advisory board member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. A.R. is an employee of Genentech from 1 August 2020 with equity in Roche. T.B., S.G. and T.J. are employees of Genentech from 1 Feburary 2021, 29 March 2021 and 5 June 2023, respectively. J.S. is a scientific advisor for Arcadia Science. A patent application has been filed by the Broad Institute related to this work. The other authors declare no competing interests.